Moderna and Vertex in New Collaboration to Treat CF Using Gene Editing
- Posted by ISPE Boston
- On October 1, 2020
Moderna and Vertex have announced a new strategic research collaboration and licensing agreement aimed at the discovery and development of lipid nanoparticles (LNPs) and mRNAs for the delivery of gene-editing therapies for the treatment of cystic fibrosis (CF). The three-year research collaboration initially will focus on the discovery and optimization of novel LNPs and mRNAs that […]
Read More